Novel rapamycin analogs and uses thereof are disclosed herein. The rapamycin analogs of the present disclosure show increased mTORC1 specificity and lowered mTORC2 specificity relative to rapamycin.
Novel rapamycin analogs and uses thereof are disclosed herein. The rapamycin analogs of the present disclosure show increased mTORC1 specificity and lowered mTORC2 specificity relative to rapamycin.
RAPAMYCIN ANALOGS AND USES THEREOF
申请人:Anakuria Therapeutics, Inc.
公开号:US20220267352A1
公开(公告)日:2022-08-25
The present invention provides compounds, compositions thereof, and methods of using the same.
[EN] MTORC1 MODULATORS AND USES THEREOF<br/>[FR] MODULATEURS DE MTORC1 ET LEURS UTILISATIONS
申请人:AEOVIAN PHARMACEUTICALS INC
公开号:WO2021195599A1
公开(公告)日:2021-09-30
The disclosure provides compounds and salts that show high selectivity and inhibitory activity for mTORC1 and uses thereof for the treatment of disease.
Enantioselective reduction of α-substituted ketones mediated by the boronate ester TarB-NO2
A facile and mild reduction procedure is reported for the preparation of chiral secondary alcohols prepared from α-substituted ketones using sodium borohydride and the chiral boronate ester (l)-TarB-NO2. Direct reduction of substituted ketones bearing Lewis basic heteroatoms generally provided secondary alcohols of only modest enantiomeric excess likely due to either competition between the target